BioReference Laboratories Posts 14 Percent Q2 Revenue Growth | GenomeWeb

NEW YORK (GenomeWeb) – BioReference Laboratories today reported that its second quarter revenues increased 14 percent year over year, growth that it partly attributed to its genetics testing business.

The Elmwood Park, NJ-based clinical lab brought in total revenues of $201.4 million for the three months ended April 30, up from $176.5 million for the second quarter of 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.